SIM
ACAD icon

Sonora Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Sonora Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,800
Closed -$51.9K – 938
2016
Q4 		$51.9K Buy
+1,800
New +$47.6K 0.01% 289
2016
Q1 		– Sell
-3,100
Closed -$111K – 964
2015
Q4 		$111K Hold
3,100
– – 0.03% 159
2015
Q3 		$122K Buy
+3,100
New +$129K 0.04% 139

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Sonora Investment Management's ACAD Position: Q1 2017 in Review

Sonora Investment Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2017, closing a stake of 1,800 shares — an estimated $51.9K sold.

Sonora Investment Management first reported a position in ACAD in Q3 2015 and held it in 3 quarters. The position peaked at $122K in Q3 2015. 219 funds tracked by Wall St. Rank hold ACAD as of Q1 2017.

  • Sonora Investment Management reported no remaining Acadia Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Sonora Investment Management sold 1,800 Acadia Pharmaceuticals shares in Q1 2017, an estimated $51.9K.
  • Sonora Investment Management first reported a position in Acadia Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Sonora Investment Management's Acadia Pharmaceuticals position peaked at $122K in Q3 2015.
  • 219 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2017.

Based on Sonora Investment Management's 13F filing for Q1 2017, filed 21 Jul 2017.